Neurocrine Biosciences (NBIX) EV to FCF (2018 - 2026)
Neurocrine Biosciences' EV to FCF came in at 19.23 for Q2 2026, down 11.4% from 21.69 a year earlier but up 33.9% from the prior quarter.
Powered by 
Analysis
Neurocrine Biosciences (NBIX) EV to FCF (2018 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Neurocrine Biosciences reported EV to FCF of 14.73, down 5.2% year-over-year; for FY2025, it was 16.99, down 24.2% from FY2024.
- Going back by year, EV to FCF was 22.42 in FY2024 (-32.2%), 33.09 in FY2023 (+1.5%), 32.61 in FY2022 (+3.2%) and 31.61 in FY2021 (-15.7%).
- The five-year range for quarterly EV to FCF is 14.36 (Q1 2026) to 81.10 (Q1 2022).
- Year-over-year, EV to FCF has declined for ten consecutive quarters, with an average decline of 16.5% over the last eight quarters.
- The fastest year-over-year change in EV to FCF over five years came in Q1 2022 (growth of 159.6%), and the weakest in Q2 2023 (a decline of 55.2%).
- Business Quant data shows NBIX's EV to FCF at 14.36 (Q1 2026), 16.99 (Q4 2025) and 21.72 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Neurocrine Biosciences | 14.41 Bn | 10.11 Bn | 935.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 19.23 |
| Mar 31, 2026 | 14.36 |
| Dec 31, 2025 | 16.99 |
| Sep 30, 2025 | 21.72 |
| Jun 30, 2025 | 21.69 |
| Mar 31, 2025 | 20.33 |
| Dec 31, 2024 | 22.42 |
| Sep 30, 2024 | 23.70 |
| Jun 30, 2024 | 25.98 |
| Mar 31, 2024 | 20.61 |
| Dec 31, 2023 | 33.09 |
| Sep 30, 2023 | 25.87 |
| Jun 30, 2023 | 29.30 |
| Mar 31, 2023 | 37.82 |
| Dec 31, 2022 | 32.61 |
| Sep 30, 2022 | 53.15 |
| Jun 30, 2022 | 65.39 |
| Mar 31, 2022 | 81.10 |
| Dec 31, 2021 | 31.61 |
| Sep 30, 2021 | 25.40 |
API Access
Neurocrine Biosciences EV to FCF API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-fcf&ticker=NBIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-fcf", "ticker": "NBIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-fcf&ticker=NBIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();